Home / CLPBF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CLPBF make money? Does CLPBF have pricing power? What's the Earnings Whisper? Will CLPBF profit more as the business scales? What is CLPBF's management track record? Is CLPBF's current price justified?

Coloplast A/S

$68.33 -$15.37 (-18.36%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$68.33

Day Range

$65.16$68.33

Year Range

$56.81$98.58

Market Cap

14.17B

AVG Volume

1.35K

Trailing/Forward PE

33.94/2.57

PEG ratio

9.05

Dividend Yield

5.53%

Next Earnings Date

2026-11-03

Primary Exchange

Other OTC

Revenue (DKK)

CLPBF Revenue (DKK) by year
Period	Revenue (DKK)
2025	27.86B
2024	27.03B
2023	24.5B
2022	22.58B
2021	19.43B
2020	18.54B
2019	17.94B
2018	16.45B
2017	15.53B
2016	14.68B

Net Income (DKK)

CLPBF Net Income (DKK) by year
Period	Net Income (DKK)
2025	3.63B
2024	5.05B
2023	4.78B
2022	4.71B
2021	4.83B
2020	4.2B
2019	3.87B
2018	3.85B
2017	3.8B
2016	3.14B

Operating Income (DKK)

CLPBF Operating Income (DKK) by year
Period	Operating Income (DKK)
2025	7.55B
2024	7.35B
2023	6.77B
2022	6.44B
2021	6.36B
2020	5.85B
2019	5.16B
2018	5.07B
2017	5.02B
2016	4.1B

EBITDA (DKK)

CLPBF EBITDA (DKK) by year
Period	EBITDA (DKK)
2025	8.8B
2024	8.49B
2023	7.98B
2022	7.37B
2021	7.16B
2020	6.59B
2019	6.19B
2018	5.69B
2017	5.62B
2016	4.65B

Cash Flows (DKK)

CLPBF Cash Flows (DKK) by year
Period	Cash Flows (DKK)
2025	5.24B
2024	1.42B
2023	2.98B
2022	3.96B
2021	3.32B
2020	3.83B
2019	3.72B
2018	3.69B
2017	2.57B
2016	2.38B

EPS (DKK)

CLPBF EPS (DKK) by year
Period	EPS (DKK)
2025	16.13
2024	22.62
2023	22.2
2022	22.1
2021	22.64
2020	19.68
2019	18.18
2018	18.11
2017	17.88
2016	14.77

Expenses (DKK)

CLPBF Expenses (DKK) by year
Period	Expenses (DKK)
2025	12.77B
2024	12.33B
2023	10.75B
2022	9.8B
2021	8.97B
2020	7.72B
2019	7.29B
2018	6.68B
2017	6.25B
2016	5.85B

Cash & Debt (DKK)

CLPBF Cash & Debt (DKK) by year
Period	Cash & Debt (DKK)
2025	945.2M
2024	788M
2023	911M
2022	633M
2021	674M
2020	585M
2019	669M
2018	607M
2017	629M
2016	1.03B

Debt ratios

CLPBF Debt ratios by year
Period	Debt ratios
2025	0.66
2024	0.7
2023	0.64
2022	0.66
2021	0.08
2020	0.05
2019	0.02
2018	0.04

Margins

CLPBF Margins by year
Period	Margins
2025	67.97%
2024	67.59%
2023	66.64%
2022	68.78%
2021	68.53%
2020	68.01%
2019	67.75%
2018	67.27%
2017	68.08%
2016	68.33%

Return on Capital

CLPBF Return on Capital by year
Period	Return on Capital
2025	22.59%
2024	28.16%
2023	27.65%
2022	56.75%
2021	59.07%
2020	56.67%
2019	56.02%
2018	59.91%
2017	63.79%
2016	62.02%

Shares Outstanding

CLPBF Shares Outstanding by year
Period	Shares Outstanding
2025	225.37M
2024	225M
2023	218.4M
2022	212.31M
2021	213.24M
2020	213.32M
2019	212.86M
2018	212.47M
2017	212.55M
2016	212M

Dividends (DKK)

CLPBF Dividends (DKK) by year
Period	Dividends (DKK)
2026	0.78
2025	3.56
2024	3.14
2023	3.05
2022	2.83
2021	2.95
2020	2.85
2019	2.53
2018	2.48
2017	6.16

Book Value Per Share (DKK)

CLPBF Book Value Per Share (DKK) by year
Period	Book Value Per Share (DKK)
2025	71.4
2024	79.74
2023	79.21
2022	39.06
2021	38.31
2020	34.72
2019	32.48
2018	30.21
2017	28
2016	23.91

Total Assets (DKK)

CLPBF Total Assets (DKK) by year
Period	Total Assets (DKK)
2025	48.27B
2024	48.07B
2023	48.16B
2022	34.96B
2021	15.84B
2020	13.5B
2019	12.73B
2018	11.77B
2017	12.05B
2016	11.01B

PE Ratio

CLPBF PE Ratio by year
Period	PE Ratio
Sep 26	47.18
Sep 26	47.12
Aug 26	47.25
Aug 26	46.87
Aug 26	45.01
Aug 26	45.25
Jul 26	46.28
Jul 26	45.08
Jul 26	42.06
Jul 26	43.33
Jul 26	42.36
Jun 26	21.27
Jun 26	20.98
Jun 26	21.81
Jun 26	21.1
May 26	21.88
May 26	22.89
May 26	21.9
May 26	23.3
May 26	23.11
Apr 26	23.93
Apr 26	24.67
Apr 26	23.49
Apr 26	24.29
Mar 26	26.76
Mar 26	26.83
Mar 26	28.39
Mar 26	28.02
Feb 26	30.2
Feb 26	29.79
Feb 26	29.57
Feb 26	31.36
Jan 26	32.6
Jan 26	32.97
Jan 26	35.88
Jan 26	35.11
Jan 26	33.08
Dec 25	29.38
Dec 25	30.18
Dec 25	31.09
Dec 25	32.29
Nov 25	32.19
Nov 25	32.43
Nov 25	33.92
Nov 25	33.63
Oct 25	32.4
Oct 25	32.06
Oct 25	30.57
Oct 25	30.4
Oct 25	30.08
Sep 25	27.23
Sep 25	29.08
Sep 25	31.1
Sep 25	30.59
Aug 25	30.67
Aug 25	30.9
Aug 25	29.91
Aug 25	29.45
Aug 25	29.58
Jul 25	30.24
Jul 25	30.22
Jul 25	29.52
Jul 25	28.51
Jun 25	26.6
Jun 25	27.05
Jun 25	29.78
Jun 25	28.36
May 25	29.48
May 25	29.04
May 25	30.53
May 25	30.3
May 25	31.75
Apr 25	32.22
Apr 25	29.89
Apr 25	29.9
Apr 25	31.26
Mar 25	31.96
Mar 25	32.56
Mar 25	32.07
Mar 25	32
Feb 25	34.94
Feb 25	34.32
Feb 25	35.15
Feb 25	35.36
Jan 25	36.28
Jan 25	35.26
Jan 25	36.02
Jan 25	34.32
Jan 25	33.99
Dec 24	35.37
Dec 24	36.47
Dec 24	36.21
Dec 24	38.76
Nov 24	41.08
Nov 24	39.24
Nov 24	39.96
Nov 24	40.99
Nov 24	40.44
Oct 24	39.53
Oct 24	40.47

Free Cash Flow Yield

CLPBF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	6.07%
Sep 26	6.08%
Aug 26	6.06%
Aug 26	6.11%
Aug 26	6.37%
Aug 26	6.33%
Jul 26	6.19%
Jul 26	6.35%
Jul 26	6.81%
Jul 26	6.61%
Jul 26	6.76%
Jun 26	6.36%
Jun 26	6.45%
Jun 26	6.2%
Jun 26	6.41%
May 26	6.19%
May 26	5.91%
May 26	6.18%
May 26	5.81%
May 26	5.85%
Apr 26	5.65%
Apr 26	5.48%
Apr 26	5.76%
Apr 26	5.57%
Mar 26	5.38%
Mar 26	5.37%
Mar 26	5.08%
Mar 26	5.14%
Feb 26	4.77%
Feb 26	4.84%
Feb 26	4.87%
Feb 26	4.6%
Jan 26	4.42%
Jan 26	4.37%
Jan 26	4.02%
Jan 26	4.1%
Jan 26	4.36%
Dec 25	4.13%
Dec 25	4.02%
Dec 25	3.9%
Dec 25	3.76%
Nov 25	3.77%
Nov 25	3.74%
Nov 25	3.58%
Nov 25	3.61%
Oct 25	3.75%
Oct 25	3.79%
Oct 25	3.97%
Oct 25	3.99%
Oct 25	4.04%
Sep 25	3.94%
Sep 25	3.69%
Sep 25	3.45%
Sep 25	3.51%
Aug 25	3.5%
Aug 25	3.47%
Aug 25	3.59%
Aug 25	3.64%
Aug 25	3.63%
Jul 25	3.55%
Jul 25	3.55%
Jul 25	3.63%
Jul 25	3.76%
Jun 25	1.24%
Jun 25	1.22%
Jun 25	1.1%
Jun 25	1.16%
May 25	1.12%
May 25	1.13%
May 25	1.08%
May 25	1.09%
May 25	1.04%
Apr 25	1.02%
Apr 25	1.1%
Apr 25	1.1%
Apr 25	1.05%
Mar 25	0.88%
Mar 25	0.86%
Mar 25	0.88%
Mar 25	0.88%
Feb 25	0.8%
Feb 25	0.82%
Feb 25	0.8%
Feb 25	0.79%
Jan 25	0.77%
Jan 25	0.8%
Jan 25	0.78%
Jan 25	0.82%
Jan 25	0.83%
Dec 24	0.75%
Dec 24	0.72%
Dec 24	0.73%
Dec 24	0.68%
Nov 24	0.64%
Nov 24	0.67%
Nov 24	0.66%
Nov 24	0.64%
Nov 24	0.65%
Oct 24	0.67%
Oct 24	0.65%

Price to Sales

CLPBF Price to Sales by year
Period	Price to Sales
Sep 26	3.54
Sep 26	3.53
Aug 26	3.54
Aug 26	3.52
Aug 26	3.38
Aug 26	3.39
Jul 26	3.47
Jul 26	3.38
Jul 26	3.16
Jul 26	3.25
Jul 26	3.18
Jun 26	3.04
Jun 26	3
Jun 26	3.12
Jun 26	3.02
May 26	3.13
May 26	3.27
May 26	3.13
May 26	3.33
May 26	3.31
Apr 26	3.42
Apr 26	3.53
Apr 26	3.36
Apr 26	3.47
Mar 26	3.49
Mar 26	3.5
Mar 26	3.7
Mar 26	3.66
Feb 26	3.94
Feb 26	3.89
Feb 26	3.86
Feb 26	4.09
Jan 26	4.25
Jan 26	4.3
Jan 26	4.68
Jan 26	4.58
Jan 26	4.32
Dec 25	4.3
Dec 25	4.41
Dec 25	4.55
Dec 25	4.72
Nov 25	4.71
Nov 25	4.74
Nov 25	4.96
Nov 25	4.92
Oct 25	4.74
Oct 25	4.69
Oct 25	4.47
Oct 25	4.45
Oct 25	4.4
Sep 25	4.45
Sep 25	4.75
Sep 25	5.08
Sep 25	5
Aug 25	5.01
Aug 25	5.05
Aug 25	4.89
Aug 25	4.81
Aug 25	4.84
Jul 25	4.94
Jul 25	4.94
Jul 25	4.83
Jul 25	4.66
Jun 25	4.73
Jun 25	4.81
Jun 25	5.3
Jun 25	5.05
May 25	5.25
May 25	5.17
May 25	5.43
May 25	5.39
May 25	5.65
Apr 25	5.73
Apr 25	5.32
Apr 25	5.32
Apr 25	5.56
Mar 25	5.97
Mar 25	6.09
Mar 25	5.99
Mar 25	5.98
Feb 25	6.53
Feb 25	6.41
Feb 25	6.57
Feb 25	6.61
Jan 25	6.78
Jan 25	6.59
Jan 25	6.73
Jan 25	6.41
Jan 25	6.35
Dec 24	6.68
Dec 24	6.89
Dec 24	6.84
Dec 24	7.32
Nov 24	7.76
Nov 24	7.41
Nov 24	7.55
Nov 24	7.74
Nov 24	7.64
Oct 24	7.46
Oct 24	7.64

EV/EBITDA

CLPBF EV/EBITDA by year
Period	EV/EBITDA
Sep 26	10.48
Sep 26	10.47
Aug 26	10.49
Aug 26	10.42
Aug 26	10.09
Aug 26	10.13
Jul 26	10.32
Jul 26	10.1
Jul 26	9.56
Jul 26	9.79
Jul 26	9.61
Jun 26	12.53
Jun 26	12.4
Jun 26	12.78
Jun 26	12.45
May 26	12.81
May 26	13.27
May 26	12.82
May 26	13.46
May 26	13.37
Apr 26	13.75
Apr 26	14.09
Apr 26	13.55
Apr 26	13.92
Mar 26	13.51
Mar 26	13.54
Mar 26	14.19
Mar 26	14.03
Feb 26	14.93
Feb 26	14.76
Feb 26	14.67
Feb 26	15.41
Jan 26	15.92
Jan 26	16.08
Jan 26	17.28
Jan 26	16.96
Jan 26	16.12
Dec 25	16.35
Dec 25	16.73
Dec 25	17.15
Dec 25	17.7
Nov 25	17.66
Nov 25	17.77
Nov 25	18.46
Nov 25	18.33
Oct 25	17.76
Oct 25	17.6
Oct 25	16.91
Oct 25	16.83
Oct 25	16.68
Sep 25	16.77
Sep 25	17.73
Sep 25	18.77
Sep 25	18.51
Aug 25	18.55
Aug 25	18.67
Aug 25	18.16
Aug 25	17.92
Aug 25	17.99
Jul 25	18.33
Jul 25	18.32
Jul 25	17.96
Jul 25	17.43
Jun 25	17.56
Jun 25	17.81
Jun 25	19.33
Jun 25	18.54
May 25	19.17
May 25	18.92
May 25	19.75
May 25	19.63
May 25	20.43
Apr 25	20.69
Apr 25	19.39
Apr 25	19.4
Apr 25	20.16
Mar 25	21.58
Mar 25	21.94
Mar 25	21.65
Mar 25	21.61
Feb 25	23.36
Feb 25	22.99
Feb 25	23.48
Feb 25	23.61
Jan 25	24.15
Jan 25	23.55
Jan 25	24
Jan 25	22.99
Jan 25	22.79
Dec 24	23.27
Dec 24	23.92
Dec 24	23.77
Dec 24	25.28
Nov 24	26.66
Nov 24	25.57
Nov 24	26
Nov 24	26.61
Nov 24	26.28
Oct 24	25.74
Oct 24	26.3

Price/Operating Cashflow

CLPBF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	13.08
Sep 26	13.06
Aug 26	13.1
Aug 26	12.99
Aug 26	12.48
Aug 26	12.54
Jul 26	12.83
Jul 26	12.5
Jul 26	11.66
Jul 26	12.01
Jul 26	11.74
Jun 26	12.36
Jun 26	12.19
Jun 26	12.67
Jun 26	12.26
May 26	12.71
May 26	13.3
May 26	12.73
May 26	13.54
May 26	13.43
Apr 26	13.91
Apr 26	14.34
Apr 26	13.65
Apr 26	14.12
Mar 26	14.65
Mar 26	14.68
Mar 26	15.54
Mar 26	15.34
Feb 26	16.53
Feb 26	16.3
Feb 26	16.18
Feb 26	17.16
Jan 26	17.84
Jan 26	18.04
Jan 26	19.63
Jan 26	19.21
Jan 26	18.1
Dec 25	18.62
Dec 25	19.13
Dec 25	19.71
Dec 25	20.47
Nov 25	20.41
Nov 25	20.56
Nov 25	21.5
Nov 25	21.32
Oct 25	20.54
Oct 25	20.32
Oct 25	19.38
Oct 25	19.27
Oct 25	19.07
Sep 25	19.68
Sep 25	21.02
Sep 25	22.48
Sep 25	22.11
Aug 25	22.17
Aug 25	22.34
Aug 25	21.62
Aug 25	21.28
Aug 25	21.38
Jul 25	21.85
Jul 25	21.84
Jul 25	21.34
Jul 25	20.61
Jun 25	43.51
Jun 25	44.25
Jun 25	48.72
Jun 25	46.4
May 25	48.24
May 25	47.51
May 25	49.95
May 25	49.58
May 25	51.95
Apr 25	52.72
Apr 25	48.9
Apr 25	48.92
Apr 25	51.14
Mar 25	58.37
Mar 25	59.47
Mar 25	58.58
Mar 25	58.44
Feb 25	63.81
Feb 25	62.69
Feb 25	64.2
Feb 25	64.58
Jan 25	66.26
Jan 25	64.4
Jan 25	65.8
Jan 25	62.68
Jan 25	62.09
Dec 24	67.6
Dec 24	69.7
Dec 24	69.21
Dec 24	74.07
Nov 24	78.51
Nov 24	74.99
Nov 24	76.37
Nov 24	78.33
Nov 24	77.28
Oct 24	75.54
Oct 24	77.35

Price to Book

CLPBF Price to Book by year
Period	Price to Book
Sep 26	7.72
Sep 26	7.71
Aug 26	7.73
Aug 26	7.67
Aug 26	7.36
Aug 26	7.4
Jul 26	7.57
Jul 26	7.38
Jul 26	6.88
Jul 26	7.09
Jul 26	6.93
Jun 26	6.14
Jun 26	6.06
Jun 26	6.3
Jun 26	6.09
May 26	6.32
May 26	6.61
May 26	6.33
May 26	6.73
May 26	6.68
Apr 26	6.91
Apr 26	7.13
Apr 26	6.78
Apr 26	7.02
Mar 26	6.04
Mar 26	6.06
Mar 26	6.41
Mar 26	6.33
Feb 26	6.82
Feb 26	6.73
Feb 26	6.68
Feb 26	7.08
Jan 26	7.36
Jan 26	7.45
Jan 26	8.1
Jan 26	7.93
Jan 26	7.47
Dec 25	7.28
Dec 25	7.48
Dec 25	7.7
Dec 25	8
Nov 25	7.98
Nov 25	8.04
Nov 25	8.4
Nov 25	8.33
Oct 25	8.03
Oct 25	7.94
Oct 25	7.57
Oct 25	7.53
Oct 25	7.45
Sep 25	7.3
Sep 25	7.8
Sep 25	8.34
Sep 25	8.2
Aug 25	8.23
Aug 25	8.29
Aug 25	8.02
Aug 25	7.9
Aug 25	7.93
Jul 25	8.11
Jul 25	8.11
Jul 25	7.92
Jul 25	7.65
Jun 25	8.4
Jun 25	8.54
Jun 25	9.41
Jun 25	8.96
May 25	9.31
May 25	9.17
May 25	9.64
May 25	9.57
May 25	10.03
Apr 25	10.18
Apr 25	9.44
Apr 25	9.44
Apr 25	9.87
Mar 25	9
Mar 25	9.17
Mar 25	9.03
Mar 25	9.01
Feb 25	9.84
Feb 25	9.66
Feb 25	9.9
Feb 25	9.96
Jan 25	10.21
Jan 25	9.93
Jan 25	10.14
Jan 25	9.66
Jan 25	9.57
Dec 24	10.63
Dec 24	10.96
Dec 24	10.89
Dec 24	11.65
Nov 24	12.35
Nov 24	11.79
Nov 24	12.01
Nov 24	12.32
Nov 24	12.15
Oct 24	11.88
Oct 24	12.17

No video analysis for this stock yet. Request one from our team.

News: CLPBF

reuters.com · 18 Aug 2026

Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says

Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient settings to fall sharply, its finance chief ‌told Reuters on Tuesday.

seekingalpha.com · 5 Aug 2026

Coloplast Might Have Found Its Bottom

Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion Kerecis impairment and currency headwinds. Management guides for 5–6% organic revenue growth and 5% EBIT growth in FY25/26, but targets 7–8% annual organic growth and 20%+ ROIC by FY29/30.

AI Analysis

Coloplast A/S

Video analysis: CLPBF

News: CLPBF

Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says

Coloplast Might Have Found Its Bottom

Similar companies